Me if it were 2019
We were supposed to have these
Me if it were 2019
We were supposed to have these results before Christmas so something is definitely up. It’s gotta be huge. Think about it. Nobody has a drug for Nash. The FDA has probably stepped in to tell us to hold off on the announcement of results because they’re planning on some sort of immediate approval or breakthrough designation. Nader wouldn’t let that timeline get out if he wasn’t planning on hitting it. This is serious. Every major news outlet is going to lead with this story. Expect the president to address the results later this week. I’ll probably buy three cars. A luxury daily driver like a decked out Rover, a sports car from my youth like Magnum P.I.’s Ferrari, and maybe import a dope Landcruiser from Costa Rica you can’t get here in the states. What’s the largest size vault a civilian can buy? Asking for a friend who’s about to have a lot of cash.
Me if it were 2020
We were supposed to have these results before Christmas so something is up. The 350mg group was strong so I see no reason why 700mg wouldn’t be better. They’re probably just waiting on their partner. After all, they’ve said that companies are waiting on results and want to see them as soon as we have them. If they’re strong like I believe them to be, then this partner has the abacas out and is finalizing their offer before the rest of the world knows. That’s how I’d do it. I strongly believe that this delay is a positive one. Imagine having proof of the world’s first Nash drug in the hands of your statisticians. It would behoove you to take your time and get it right. The world can wait a few days. I wonder who the partner would be? Literally every big pharma company wants in on Nash. It’s going to be a bidding war if it’s good. This could be it, guys. The news we need to catapult this baby into beach house territory. I’ll probably buy three lots next to each other, build a guest house/rental house on one plot and a massive house with a pool and outdoor kitchen on the other two lots. Crossing my fingers hard. C'mon, big results no whammies!
Me now, at the end of 2021
Fuck me, it’s bad isn’t it. I mean, NP and the gang miss timelines all the time so it’s not that abnormal, but he was only a week and a half away from when he was predicting topline data. What went wrong? If I close my eyes I can almost see NP frustratedly staring at a spreadsheet of results and pondering whether or not we could break out just the left handed patients to see a stronger numbers. I knew I should have left that 10k in my account in case there was a delay or poor results that dropped the price for a few days. Now I have to sell something and let it clear first before I can buy. Fuck me, it’s going to be like, three days before I can buy. Goddamnit Nader!
Me when results come out and they’re strong like I originally thought
I KNEW IT! NEVER DOUBTED MYSELF OR THE COMPANY LET’S DO THIS I’M GETTING WAGYU TONIGHT BABY!!!
#TechnicalAnalysis #Wagyu
30
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...
Continue Reading
107 years in the game, and the Communist Party of China (CPC) isn't showing any signs of slowing. With their recent conference in Beijing focusing on Xi Jinping Thought on Party Building, it’s clear they’ve got their eyes on the future, not just resting on past laurels. This Xi Jinping Thought is about a thorough self-improvement plan for the Party, a clear strategy...
Continue Reading
A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...
Continue Reading
Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...
Continue Reading
Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...
Continue Reading
Fifteen years of soaring high: now that's something worth taking to the bank—or the air. Hainan Airlines has just bagged the SKYTRAX Five-Star Airline rating once again, handed out at this year's World Airline Awards ceremony. When it comes to delivering quality, they're flying high on the charts, landing among the World's Best Airlines Top 10. And in the wild world of...
Continue Reading
Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...
Continue Reading
Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...
Continue Reading
Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...
Continue Reading
A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...
Continue Reading
Top 5 Most Recently Viewed Articles
transcosmos Embraces Good Giving Mark Certification Promoting initiatives to enhance the reliability of NPO support transcosmos has proudly announced its registration as a participant in the Good Giving Mark Certification System, operated by an independent foundation dedicated to evaluating non-profit organizations. This aligns with the organization’s commitment to...
Continue Reading
Understanding Spartan Capital's Q2 2025 Performance Overview Spartan Capital Securities, LLC has released a comprehensive analysis of its Q2 2025 performance, providing valuable insights into recent market trends. The report, crafted by seasoned market strategist Gianpaolo Raffo, delves into macroeconomic factors, sector movements, and technical analysis, giving investors...
Continue Reading
AstraZeneca Investors May Pursue Class Action Opportunity Attention all investors of AstraZeneca PLC! There’s an important update for those who may have incurred losses in their investments. A law firm has announced the chance to join a class action lawsuit against AstraZeneca. This could be a significant step for shareholders who feel wronged due to alleged misconduct...
Continue Reading
Thermo Fisher Scientific's Renewable Energy Innovations Thermo Fisher Scientific Inc. (NYSE: TMO), a front-runner in the realm of scientific services, has announced an ambitious initiative aimed at achieving 100 percent renewable electricity for its European operations. This feat is being pursued through a virtual power purchasing agreement (VPPA) with X-ELIO, an esteemed...
Continue Reading
Align Technology's Strategic Stock Repurchase Plan Align Technology, Inc. (NASDAQ: ALGN) has recently seen its stock price rise by 3%, reaching $223.00 in the morning. This uptick follows the company revealing its intention to repurchase $275 million worth of shares as part of a larger $1 billion stock repurchase initiative. The announcement has sparked interest among...
Continue Reading